CD274 and neoplasm: When including only tumours with high ICS, the 5-year survival in cases with CPS negative vs. positive PD-L1 was 69.2% vs. 53.1% (p = 0.317, Fig. 3a); for PD-1 positive lymphocytes 70.6% vs. 55.3% (p = 0.312, Fig. 3b); and for Clever-1 positive macrophages 72.0% vs. 45.5% (p = 0.070, Fig. 3c).